mirId	Cancer	Profile	PubMed Article
hsa-let-7a	breast cancer	down	MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.
hsa-let-7a	breast cancer	down	The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.
hsa-let-7a	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-let-7a	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-let-7a	gastric cancer	down	Investigation and identification of let-7a related functional proteins in gastric carcinoma by proteomics.
hsa-let-7a	gastric cancer	down	Differentially expressed proteins identified in overexpressed let-7a gastric carcinoma cells by two-dimensional polyacrylamide gel electrophoresis.
hsa-let-7a	gastric cancer	down	Circulating microRNAs in plasma of patients with gastric cancers.
hsa-let-7a	gastric cancer	down	Lentiviral vector-mediated upregulation of let-7a inhibits gastric carcinoma cell growth in vitro and in vivo.
hsa-let-7a	gastric cancer	down	Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C.
hsa-let-7a	non-small cell lung cancer	down	Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-let-7a	renal cell carcinoma	down	Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc.
hsa-let-7b	acute lymphoblastic leukemia	down	Suppression of the let-7b microRNA pathway by DNA hypermethylation in infant acute lymphoblastic leukemia with MLL gene rearrangements.
hsa-let-7b	breast cancer	down	The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.
hsa-let-7b	breast cancer	down	Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-let-7b	malignant melanoma	down	MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth.
hsa-let-7c	acute myeloid leukemia	down	miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia.
hsa-let-7c	acute promyelocytic leukemia	down	A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.
hsa-let-7c	prostate cancer	down	MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells.
hsa-let-7c	prostate cancer	down	MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth.
hsa-let-7d	head and neck squamous cell carcinoma	down	Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
hsa-let-7d	oral cancer	down	Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer.
hsa-let-7d	pancreatic ductal adenocarcinoma	down	MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors.
hsa-let-7g	breast cancer	down	The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.
hsa-mir-1	bladder cancer	down	The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.
hsa-mir-1	head and neck squamous cell carcinoma	down	Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
hsa-mir-1	head and neck squamous cell carcinoma	down	miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma.
hsa-mir-1	lung cancer	down	Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.
hsa-mir-1	renal cell carcinoma	down	The functional significance of miR-1 and miR-133a in renal cell carcinoma.
hsa-mir-100	breast cancer	down	miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling.
hsa-mir-100	esophageal squamous cell carcinoma	down	MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma.
hsa-mir-100	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-100	hepatocellular carcinoma	down	Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.
hsa-mir-100	non-small cell lung cancer	down	MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
hsa-mir-100	oral squamous cell carcinoma	down	Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy.
hsa-mir-100	ovarian carcinoma	down	Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.
hsa-mir-100	renal cell carcinoma	up	Overexpression of microRNA-100 predicts an unfavorable prognosis in renal cell carcinoma.
hsa-mir-101	bladder cancer	down	MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met.
hsa-mir-101	cholangiocarcinoma	down	miR-101 inhibits cholangiocarcinoma angiogenesis through targeting vascular endothelial growth factor (VEGF).
hsa-mir-101	colon cancer	down	Loss of miR-101 Expression Promotes Wnt/?-Catenin Signalling Pathway Activation and Malignancy in Colon Cancer Cells.
hsa-mir-101	gastric cancer	down	Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer.
hsa-mir-101	gastric cancer	down	Down-regulation of miR-101 in gastric cancer correlates with COX-2 overexpression and tumor growth.
hsa-mir-101	gastric cancer	down	MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion.
hsa-mir-101	gastric cancer	down	MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion.
hsa-mir-101	glioblastoma	down	miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis.
hsa-mir-101	hepatocellular carcinoma	down	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-mir-101	hepatocellular carcinoma	down	miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells.
hsa-mir-101	lung cancer	down	microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2.
hsa-mir-101	non-small cell lung cancer	down	MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
hsa-mir-101	non-small cell lung cancer	down	MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance.
hsa-mir-101	prostate cancer	down	Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo.
hsa-mir-103	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-106a	cervical squamous cell carcinoma	down	MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma.
hsa-mir-106a	colorectal cancer	up	Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
hsa-mir-106a	gastric cancer	up	Circulating microRNAs in plasma of patients with gastric cancers.
hsa-mir-106a	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-106a	gastric cancer	up	miR-106a Is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS.
hsa-mir-106a	gastric cancer	up	Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.
hsa-mir-106a	glioma	down	MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.
hsa-mir-106a	non-small cell lung cancer	down	Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-106b	gastric cancer	up	Circulating microRNAs in plasma of patients with gastric cancers.
hsa-mir-106b	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-106b	gastric cancer	up	Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.
hsa-mir-106b	glioma	up	Down-regulation of miR-106b suppresses the growth of human glioma cells.
hsa-mir-106b	hepatocellular carcinoma	up	Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process.
hsa-mir-106b	laryngeal carcinoma	up	MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.
hsa-mir-107	acute promyelocytic leukemia	down	A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.
hsa-mir-107	gastric cancer	up	MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer.
hsa-mir-107	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-107	glioma	down	P53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2.
hsa-mir-107	glioma	down	MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression.
hsa-mir-107	head and neck squamous cell carcinoma	down	microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase C?
hsa-mir-107	head and neck squamous cell carcinoma	down	Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma.
hsa-mir-107	prostate carcinoma	down	Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene group.
hsa-mir-10a	cervical cancer	up	MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells.
hsa-mir-10a	chronic myelogenous leukemia	down	Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
hsa-mir-10a	pancreatic cancer	up	MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
hsa-mir-10b	breast cancer	down	Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-10b	esophageal cancer	up	MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines.
hsa-mir-10b	gastric cancer	up	Clinicopathologic significance of miR-10b expression in gastric carcinoma.
hsa-mir-10b	gastric cancer	up	miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer.
hsa-mir-10b	glioblastoma	up	Oncogenic effects of miR-10b in glioblastoma stem cells.
hsa-mir-10b	glioma	up	MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10.
hsa-mir-10b	hepatocellular carcinoma	up	MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells.
hsa-mir-10b	oral cancer	up	Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling.
hsa-mir-10b	pancreatic cancer	up	MicroRNA-10b is overexpressed in pancreatic cancer.
hsa-mir-10b	pancreatic cancer	up	MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.
hsa-mir-10b	pancreatic ductal adenocarcinoma	up	microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma.
hsa-mir-1179	colorectal cancer	up	MicroRNA expression profiles in human colorectal cancers with liver metastases.
hsa-mir-122	breast cancer	down	MiR-122 Inhibits Cell Proliferation and Tumorigenesis of Breast Cancer by Targeting IGF1R.
hsa-mir-122	hepatocellular carcinoma	down	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-mir-122	hepatocellular carcinoma	down	microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma.
hsa-mir-122	hepatocellular carcinoma	up	Epigenetic regulation of miR-122 by PPAR? and hepatitis B virus X protein in hepatocellular carcinoma cells.
hsa-mir-122	hepatocellular carcinoma	down	A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.
hsa-mir-122	hepatocellular carcinoma	up	Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
hsa-mir-122	hepatocellular carcinoma	down	MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.
hsa-mir-122	hepatocellular carcinoma	up	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-122	hepatocellular carcinoma	down	MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.
hsa-mir-122	hepatocellular carcinoma	down	MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/?-catenin pathway.
hsa-mir-122	hepatocellular carcinoma	down	miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells.
hsa-mir-122	liver cancer	down	MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.
hsa-mir-122	pituitary carcinoma	up	MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas.
hsa-mir-122	renal clear cell carcinoma	up	miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-1228*	gastric cancer	down	Restoration of miR-1228* expression suppresses epithelial-mesenchymal transition in gastric cancer.
hsa-mir-122a	gastrointestinal cancer	down	MicroRNA-122a functions as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal cancers.
hsa-mir-122a	hepatocellular carcinoma	down	Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
hsa-mir-122a	hepatocellular carcinoma	down	[MicroRNA profiling in patients with hepatocellular carcinoma].
hsa-mir-122a	hepatocellular carcinoma	down	Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
hsa-mir-1233	renal cell carcinoma	up	MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.
hsa-mir-124	anaplastic astrocytoma	down	miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
hsa-mir-124	breast cancer	down	miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro.
hsa-mir-124	breast cancer	down	Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer.
hsa-mir-124	breast cancer	down	MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer.
hsa-mir-124	cervical squamous cell carcinoma	down	Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.
hsa-mir-124	colorectal cancer	down	Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer.
hsa-mir-124	colorectal cancer	down	MicroRNA-124 Regulates the Proliferation of Colorectal Cancer Cells by Targeting iASPP.
hsa-mir-124	gastric cancer	down	miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1.
hsa-mir-124	glioblastoma	down	miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
hsa-mir-124	glioblastoma	down	Downregulation of miR-124 promotes the growth and invasiveness of glioblastoma cells involving upregulation of PPP1R13L.
hsa-mir-124	hepatocellular carcinoma	down	MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.
hsa-mir-124	hepatocellular carcinoma	down	The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.
hsa-mir-124	medulloblastoma	down	miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1.
hsa-mir-124	neuroblastoma	down	Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR.
hsa-mir-124	oral squamous cell carcinoma	down	MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1.
hsa-mir-124	pancreatic cancer	down	Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1.
hsa-mir-124a	acute lymphoblastic leukemia	down	Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
hsa-mir-124a	glioblastoma	down	miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion.
hsa-mir-124a	mantle cell lymphoma	up	microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-1258	breast cancer	down	The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer.
hsa-mir-1258	breast cancer	down	MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase.
hsa-mir-1259	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-125a	colorectal cancer	down	Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
hsa-mir-125a	glioblastoma	down	miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.
hsa-mir-125a-3p	gastric cancer	down	Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
hsa-mir-125a-3p	non-small cell lung cancer	down	Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
hsa-mir-125a-5p	breast cancer	down	Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-125a-5p	non-small cell lung cancer	down	Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
hsa-mir-125b	bladder cancer	down	microRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer.
hsa-mir-125b	bladder cancer	down	MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.
hsa-mir-125b	breast cancer	down	MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells.
hsa-mir-125b	breast cancer	down	Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.
hsa-mir-125b	breast cancer	down	MUCIN 1 ONCOPROTEIN EXPRESSION IS SUPPRESSED BY THE miR-125b ONCOMIR.
hsa-mir-125b	breast cancer	down	miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.
hsa-mir-125b	chronic lymphocytic leukemia	down	The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state.
hsa-mir-125b	follicular cancer	up	MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.
hsa-mir-125b	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-125b	glioblastoma	down	Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma.
hsa-mir-125b	glioma	up	MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf.
hsa-mir-125b	hepatocellular carcinoma	down	Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma.
hsa-mir-125b	hepatocellular carcinoma	down	Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer.
hsa-mir-125b	hepatocellular carcinoma	down	MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R.
hsa-mir-125b	hepatocellular carcinoma	down	MicroRNA-125b Functions as a Tumor Suppressor in Hepatocellular Carcinoma Cells.
hsa-mir-125b	hepatocellular carcinoma	down	Histone lysine methyltransferase, SUV39H1, promotes HCC progression and is negatively regulated by microRNA-125b.
hsa-mir-125b	malignant melanoma	down	MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.
hsa-mir-125b	neuroblastoma	up	MicroRNA-125b is a novel negative regulator of p53.
hsa-mir-125b	oral squamous cell carcinoma	down	Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy.
hsa-mir-125b	osteosarcoma	down	miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3.
hsa-mir-125b	ovarian cancer	down	Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis.
hsa-mir-125b	prostate cancer	up	Widespread deregulation of microRNA expression in human prostate cancer.
hsa-mir-125b	prostate cancer	up	Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.
hsa-mir-125b-2*	colorectal cancer	up	MicroRNA expression profiles in human colorectal cancers with liver metastases.
hsa-mir-126	breast cancer	down	Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2.
hsa-mir-126	colon cancer	down	MiR-126 suppresses colon cancer cell proliferation and invasion via inhibiting RhoA/ROCK signaling pathway.
hsa-mir-126	colon cancer	down	Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4.
hsa-mir-126	colorectal cancer	down	Down-regulation of miR-126 expression in colorectal cancer and its clinical significance.
hsa-mir-126	gastric cancer	down	miR-126 functions as a tumour suppressor in human gastric cancer.
hsa-mir-126	gastric cancer	up	MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis.
hsa-mir-126	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-126	hepatocellular carcinoma	down	Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma.
hsa-mir-126	non-small cell lung cancer	down	miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.
hsa-mir-126	non-small cell lung cancer	down	miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A.
hsa-mir-126	non-small cell lung cancer	down	MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients.
hsa-mir-126	non-small cell lung cancer	down	Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.
hsa-mir-126	oral squamous cell carcinoma	up	Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer.
hsa-mir-126	pancreatic ductal adenocarcinoma	down	MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors.
hsa-mir-126	small cell lung cancer	down	miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5.
hsa-mir-126*	non-small cell lung cancer	down	Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
hsa-mir-1260b	renal cell carcinoma	up	Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells.
hsa-mir-127	hepatocellular carcinoma	down	A Feedback Inhibition between miRNA-127 and TGF?/c-Jun Cascade in HCC Cell Migration via MMP13.
hsa-mir-127-3p	osteosarcoma	down	MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
hsa-mir-1271	hepatocellular carcinoma	down	A functional screening identifies five miRNAs controlling glypican-3: Role of miR-1271 down-regulation in hepatocellular carcinoma.
hsa-mir-128	acute lymphoblastic leukemia	up	Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia.
hsa-mir-128	acute myeloid leukemia	up	Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia.
hsa-mir-128	glioblastoma	down	Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation.
hsa-mir-128	glioblastoma	down	PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.
hsa-mir-128	glioma	down	Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.
hsa-mir-128	glioma	down	MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells.
hsa-mir-128	glioma	down	MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1.
hsa-mir-128	glioma	down	MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a.
hsa-mir-128	prostate cancer	down	MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells.
hsa-mir-1280	bladder cancer	down	MicroRNA-1280 Inhibits Invasion and Metastasis by Targeting ROCK1 in Bladder Cancer.
hsa-mir-1285	renal cell carcinoma	down	Tumor suppressive microRNA-1285 regulates novel molecular targets: Aberrant expression and functional significance in renal cell carcinoma.
hsa-mir-128a	medulloblastoma	down	MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence.
hsa-mir-129	breast cancer	down	[The down-regulation of miR-129 in breast cancer and its effect on breast cancer migration and motility].
hsa-mir-129-3p	gastric cancer	down	Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer.
hsa-mir-1290	colon cancer	up	Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells.
hsa-mir-1296	prostate cancer	down	Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.
hsa-mir-1297	lung adenocarcinoma	down	miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2.
hsa-mir-130a	hepatocellular carcinoma	up	Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell.
hsa-mir-130b	ovarian cancer	down	Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1.
hsa-mir-130b*	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-132	pancreatic cancer	up	miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.
hsa-mir-132	pancreatic carcinoma	down	Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
hsa-mir-133a	bladder cancer	down	The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.
hsa-mir-133a	bladder cancer	down	MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer.
hsa-mir-133a	colorectal cancer	down	Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
hsa-mir-133a	esophageal squamous cell carcinoma	down	miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
hsa-mir-133a	esophageal squamous cell carcinoma	down	CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma.
hsa-mir-133a	head and neck squamous cell carcinoma	down	Tumor suppressive microRNA-133a regulates novel targets: Moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.
hsa-mir-133a	head and neck squamous cell carcinoma	down	Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
hsa-mir-133a	lung squamous cell carcinoma	down	Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.
hsa-mir-133a	osteosarcoma	down	MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.
hsa-mir-133a	renal cell carcinoma	down	The functional significance of miR-1 and miR-133a in renal cell carcinoma.
hsa-mir-133b	bladder cancer	down	MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer.
hsa-mir-133b	cervical carcinoma	up	MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways.
hsa-mir-133b	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-133b	esophageal squamous cell carcinoma	down	miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
hsa-mir-133b	gastric cancer	down	miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer.
hsa-mir-133b	lung cancer	down	MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer.
hsa-mir-135a	breast cancer	up	miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10.
hsa-mir-135a	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-135a	colorectal cancer	up	MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro.
hsa-mir-135a	renal cell carcinoma	down	Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma.
hsa-mir-135b	colorectal cancer	up	Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.
hsa-mir-135b	colorectal cancer	up	Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
hsa-mir-135b	gastric cancer	up	[Clinicopathological significance and function of miR-135b in the occurrence and development of gastric cancer].
hsa-mir-135b	lung cancer	up	MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1.
hsa-mir-136	glioma	down	MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2.
hsa-mir-137	anaplastic astrocytoma	down	miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
hsa-mir-137	colorectal cancer	down	MicroRNA-137, an HMGA1 Target, Suppresses Colorectal Cancer Cell Invasion and Metastasis in Mice by Directly Targeting FMNL2.
hsa-mir-137	colorectal cancer	down	Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.
hsa-mir-137	gastric cancer	down	miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42.
hsa-mir-137	glioblastoma	down	miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
hsa-mir-137	glioblastoma	down	miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2.
hsa-mir-137	glioblastoma	down	MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
hsa-mir-137	neuroblastoma	down	MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A.
hsa-mir-137	squamous carcinoma	up	MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck.
hsa-mir-137	uveal melanoma	down	Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
hsa-mir-138	anaplastic thyroid carcinoma	down	Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
hsa-mir-138	chronic myelogenous leukemia	down	BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia.
hsa-mir-138	esophageal squamous cell carcinoma	down	Downregulation of miR-138 Sustains NF-?B Activation and Promotes Lipid Raft Formation in Esophageal Squamous Cell Carcinoma.
hsa-mir-138	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-138	head and neck squamous cell carcinoma	down	MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines.
hsa-mir-138	head and neck squamous cell carcinoma	down	Role of microRNA-138 as a potential tumor suppressor in head and neck squamous cell carcinoma.
hsa-mir-138	hepatocellular carcinoma	down	MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.
hsa-mir-138	non-small cell lung cancer	down	MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer.
hsa-mir-138	ovarian cancer	down	MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1?
hsa-mir-138	papillary thyroid carcinoma	down	Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
hsa-mir-138	renal clear cell carcinoma	down	MiR-138 suppresses expression of hypoxia-inducible factor 1? (HIF-1?) in clear cell renal cell carcinoma 786-O cells.
hsa-mir-139	colorectal cancer	down	Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation.
hsa-mir-139	colorectal carcinoma	down	Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation.
hsa-mir-139	glioma	down	MiR-139 Inhibits Mcl-1 Expression and Potentiates TMZ-Induced Apoptosis in Glioma.
hsa-mir-139	hepatocellular carcinoma	down	The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.
hsa-mir-139	hepatocellular carcinoma	down	Derepression of c-Fos caused by MicroRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma.
hsa-mir-139-3p	colorectal cancer	up	MicroRNA expression profiles in human colorectal cancers with liver metastases.
hsa-mir-140	non-small cell lung cancer	up	Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC.
hsa-mir-140-5p	hepatocellular carcinoma	down	MicroRNA-140-5p suppresses tumor growth and metastasis by targeting TGFBR1 and FGF9 in hepatocellular carcinoma.
hsa-mir-140-5p	liver cancer	down	MicroRNA-140-5p suppresses tumor growth and metastasis by targeting TGFBR1 and FGF9 in hepatocellular carcinoma.
hsa-mir-141	bladder cancer	up	Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?
hsa-mir-141	gastric cancer	down	Down-regulation of miR-141 in gastric cancer and its involvement in cell growth.
hsa-mir-141	non-small cell lung cancer	up	High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
hsa-mir-141	renal cell carcinoma	down	MicroRNA-141 is downregulated in human renal cell carcinoma and regulates cell survival by targeting CDC25B.
hsa-mir-141	renal clear cell carcinoma	down	Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
hsa-mir-142-3p	colon cancer	down	MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells.
hsa-mir-142-3p	hepatocellular carcinoma	down	MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells.
hsa-mir-142-3p	mantle cell lymphoma	down	microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-142-5p	lung cancer	down	Uncovering growth-suppressive MicroRNAs in lung cancer.
hsa-mir-142-5p	malt lymphoma	up	Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication.
hsa-mir-142-5p	mantle cell lymphoma	down	microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-142-5p	osteosarcoma	down	MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-143	bladder cancer	down	MicroRNA-143 as a tumor suppressor for bladder cancer.
hsa-mir-143	bladder cancer	down	MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells.
hsa-mir-143	bladder cancer	down	Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
hsa-mir-143	cervical cancer	down	miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2.
hsa-mir-143	colon cancer	down	MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells.
hsa-mir-143	colon cancer	down	The Evi1, microRNA-143, K-Ras axis in colon cancer.
hsa-mir-143	colon cancer	down	miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation.
hsa-mir-143	colon cancer	down	Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice.
hsa-mir-143	colorectal cancer	down	Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer.
hsa-mir-143	colorectal cancer	down	MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers.
hsa-mir-143	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-143	colorectal cancer	down	MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-143	colorectal carcinoma	down	[Effect of microRNA143 expression on cell proliferation in colonic carcinoma].
hsa-mir-143	colorectal carcinoma	down	MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer.
hsa-mir-143	colorectal carcinoma	down	Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
hsa-mir-143	esophageal squamous cell carcinoma	down	MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma.
hsa-mir-143	glioblastoma	down	miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells.
hsa-mir-143	glioma	down	miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells.
hsa-mir-143	nasopharyngeal carcinoma	down	MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma.
hsa-mir-143	osteosarcoma	down	A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.
hsa-mir-143	osteosarcoma	down	microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2.
hsa-mir-143	prostate cancer	down	miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice.
hsa-mir-143	prostate cancer	down	miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS.
hsa-mir-143	prostate cancer	down	MicroRNA-143 inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in prostate cancer.
hsa-mir-144	nasopharyngeal carcinoma	up	MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.
hsa-mir-145	bladder cancer	down	Aberrant expression of microRNAs in bladder cancer.
hsa-mir-145	bladder cancer	down	miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors.
hsa-mir-145	bladder cancer	down	MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells.
hsa-mir-145	bladder cancer	down	Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
hsa-mir-145	bladder cancer	down	socs7, a target gene of microRNA-145, regulates interferon-? induction through STAT3 nuclear translocation in bladder cancer cells.
hsa-mir-145	breast cancer	down	MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF.
hsa-mir-145	breast cancer	down	Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-145	breast cancer	down	miR-145 inhibits breast cancer cell growth through RTKN.
hsa-mir-145	breast cancer	down	miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells.
hsa-mir-145	cervical cancer	down	Glucocorticoid regulation of a novel HPV E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells.
hsa-mir-145	colon cancer	down	MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis.
hsa-mir-145	colon cancer	down	Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice.
hsa-mir-145	colon cancer	down	Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene.
hsa-mir-145	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-145	colorectal cancer	down	MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-145	colorectal cancer	down	Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
hsa-mir-145	colorectal carcinoma	down	Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
hsa-mir-145	esophageal squamous cell carcinoma	down	miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
hsa-mir-145	esophageal squamous cell carcinoma	down	MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma.
hsa-mir-145	glioblastoma	down	NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.
hsa-mir-145	glioma	down	MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells.
hsa-mir-145	glioma	down	NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.
hsa-mir-145	hepatocellular carcinoma	down	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-145	hepatocellular carcinoma	down	MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
hsa-mir-145	hepatocellular carcinoma	down	miR-145 suppresses cell invasion in hepatocellular carcinoma cells: miR-145 targets ADAM17.
hsa-mir-145	kidney cancer	down	MicroRNA-145 Targets the Metalloprotease ADAM17 and Is Suppressed in Renal Cell Carcinoma Patients.
hsa-mir-145	liver cancer	down	MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer.
hsa-mir-145	lung adenocarcinoma	down	Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
hsa-mir-145	lung adenocarcinoma	down	MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1.
hsa-mir-145	lung adenocarcinoma	down	microRNA-145 suppresses lung adenocarcinoma-initiating cell proliferation by targeting OCT4.
hsa-mir-145	lung adenocarcinoma	down	[miR-145 inhibits lung adenocarcinoma stem cells proliferation by targeting OCT4 gene].
hsa-mir-145	lung cancer	down	Uncovering growth-suppressive MicroRNAs in lung cancer.
hsa-mir-145	nasopharyngeal carcinoma	down	MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma.
hsa-mir-145	neuroblastoma	down	NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.
hsa-mir-145	non-small cell lung cancer	down	miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc.
hsa-mir-145	non-small cell lung cancer	down	Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.
hsa-mir-145	oral squamous cell carcinoma	down	Downregulation of miR-145 expression in oral squamous cell carcinomas and its clinical significance.
hsa-mir-145	oral squamous cell carcinoma	down	MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6.
hsa-mir-145	osteosarcoma	down	MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells.
hsa-mir-145	primary cns lymphomas	down	Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
hsa-mir-145	prostate cancer	down	Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.
hsa-mir-145	prostate cancer	down	MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.
hsa-mir-145	prostate cancer	down	The functional significance of microRNA-145 in prostate cancer.
hsa-mir-146a	breast cancer	down	Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells.
hsa-mir-146a	breast cancer	down	Clinical significance of miR-146a in gastric cancer cases.
hsa-mir-146a	gastric cancer	down	microRNA-146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer.
hsa-mir-146a	gastric cancer	up	microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-kappaB by targeting CARD10 and COPS8 in gastric cancer.
hsa-mir-146a	gastric cancer	down	MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis.
hsa-mir-146a	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-146a	gastric cancer	down	Clinical significance of miR-146a in gastric cancer cases.
hsa-mir-146a	glioma	down	MicroRNA-146a inhibits glioma development by targeting Notch1.
hsa-mir-146a	hepatocellular carcinoma	down	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-146a	hepatocellular carcinoma	up	Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
hsa-mir-146a	malignant melanoma	down	Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-146a	non-small cell lung cancer	down	miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells.
hsa-mir-146a	pancreatic cancer	down	miR-146a suppresses invasion of pancreatic cancer cells.
hsa-mir-146a	pancreatic cancer	down	Clinical significance of miR-146a in gastric cancer cases.
hsa-mir-146a	prostate cancer	down	Clinical significance of miR-146a in gastric cancer cases.
hsa-mir-146a	renal cell carcinoma	up	Carbamylated albumin stimulates microRNA-146, which is increased in human renal cell carcinoma.
hsa-mir-146b	breast cancer	down	Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells.
hsa-mir-146b	glioma	down	microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs.
hsa-mir-146b	malignant melanoma	down	Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-146b	non-small cell lung cancer	down	Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-146b	papillary thyroid carcinoma	up	MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
hsa-mir-146b	renal cell carcinoma	up	Carbamylated albumin stimulates microRNA-146, which is increased in human renal cell carcinoma.
hsa-mir-146b-5p	glioblastoma	down	MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma.
hsa-mir-147	breast cancer	down	Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer.
hsa-mir-147	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-148a	breast cancer	down	A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.
hsa-mir-148a	cervical squamous cell carcinoma	down	MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma.
hsa-mir-148a	gastric cancer	up	miR-148a promoted cell proliferation by targeting p27 in gastric cancer cells.
hsa-mir-148a	gastric cancer	down	MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
hsa-mir-148a	gastric cancer	down	MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer.
hsa-mir-148a	gastrointestinal cancer	down	MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.
hsa-mir-148a	non-small cell lung cancer	down	MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells.
hsa-mir-148a	ovarian cancer	down	Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation.
hsa-mir-148a	pancreatic ductal adenocarcinoma	down	Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.
hsa-mir-148a	pancreatic ductal adenocarcinoma	down	MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B.
hsa-mir-148b	colorectal cancer	down	MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer.
hsa-mir-148b	gastric cancer	down	MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.
hsa-mir-148b	ovarian cancer	up	Increased expression of miR-148b in ovarian carcinoma and its clinical significance.
hsa-mir-148b	ovarian carcinoma	up	Increased expression of miR-148b in ovarian carcinoma and its clinical significance.
hsa-mir-148b	pancreatic cancer	down	miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPK?1.
hsa-mir-149	gastric cancer	down	MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer.
hsa-mir-149	head and neck squamous cell carcinoma	down	The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma.
hsa-mir-149	nasopharyngeal carcinoma	up	miR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells.
hsa-mir-149	non-small cell lung cancer	down	miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1.
hsa-mir-150	chronic myelogenous leukemia	down	Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
hsa-mir-150	esophageal squamous cell carcinoma	down	MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducers ZEB1.
hsa-mir-150	gastric cancer	up	MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.
hsa-mir-150	mantle cell lymphoma	down	microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-150*	colorectal cancer	up	MicroRNA expression profiles in human colorectal cancers with liver metastases.
hsa-mir-150*	pancreatic cancer	down	Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R.
hsa-mir-151	chronic myelogenous leukemia	down	Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
hsa-mir-151-3p	osteosarcoma	up	MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
hsa-mir-152	breast cancer	down	A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.
hsa-mir-152	endometrial cancer	down	miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.
hsa-mir-152	gastrointestinal cancer	down	MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.
hsa-mir-152	glioma	down	MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3.
hsa-mir-152	ovarian cancer	down	Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation.
hsa-mir-153	glioblastoma	down	MicroRNA-153 is tumor suppressive in glioblastoma stem cells.
hsa-mir-153	prostate cancer	up	Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
hsa-mir-154	prostate cancer	down	miR-154 inhibits prostate cancer cell proliferation by targeting CCND2.
hsa-mir-155	bladder cancer	down	Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-155	breast cancer	up	Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-155	breast cancer	up	MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.
hsa-mir-155	breast cancer	up	MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer.
hsa-mir-155	breast cancer	up	[Expression and its clinical significance of miR-155 in human primary breast cancer].
hsa-mir-155	breast cancer	up	Clinical significance of MicoRNA-155 expression in human breast cancer.
hsa-mir-155	chronic lymphocytic leukemia	up	Signal Transducer and Activator of Transcription-3 Induces MicroRNA-155 Expression in Chronic Lymphocytic Leukemia.
hsa-mir-155	chronic myelogenous leukemia	down	Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
hsa-mir-155	clear cell renal cell cancer	up	microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells.
hsa-mir-155	colorectal cancer	up	Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression.
hsa-mir-155	cutaneous t-cell lymphoma	up	STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.
hsa-mir-155	diffuse large B-cell lymphoma	up	Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma.
hsa-mir-155	gastric cancer	down	microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis.
hsa-mir-155	lung cancer	up	Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells.
hsa-mir-155	lung cancer	up	MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression.
hsa-mir-155	lung cancer	up	Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia.
hsa-mir-155	malignant melanoma	down	Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-155	malignant melanoma	down	MicroRNA-155 targets the SKI gene in human melanoma cell lines.
hsa-mir-155	malt lymphoma	up	Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication.
hsa-mir-155	mantle cell lymphoma	up	microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-155	nasopharyngeal carcinoma	up	Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.
hsa-mir-155	non-small cell lung cancer	down	Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-155	ovarian cancer	down	MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.
hsa-mir-155	rectal cancer	up	The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer.
hsa-mir-155	renal clear cell carcinoma	up	miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-155	squamous carcinoma	up	Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-15a	chronic lymphocytic leukemia	down	Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.
hsa-mir-15a	chronic lymphocytic leukemia	down	miR-15 and miR-16 induce apoptosis by targeting BCL2.
hsa-mir-15a	chronic lymphocytic leukemia	down	Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
hsa-mir-15a	colorectal cancer	down	Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-15a	neuroblastoma	up	miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.
hsa-mir-15a	neuroblastoma	up	MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression.
hsa-mir-15a	pancreatic cancer	down	Dysregulation of miR-15a and miR-214 in human pancreatic cancer.
hsa-mir-15a	pancreatic cancer	up	Dysregulation of miR-15a and miR-214 in human pancreatic cancer.
hsa-mir-15a	squamous carcinoma	down	miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
hsa-mir-15b	colorectal cancer	down	Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-15b	glioma	down	MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3.
hsa-mir-15b	malignant melanoma	up	MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
hsa-mir-15b	tongue cancer	down	MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
hsa-mir-16	breast cancer	down	Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
hsa-mir-16	colorectal cancer	down	microRNA-16 represses colorectal cancer cell growth invitro by regulating the p53/survivin signaling pathway.
hsa-mir-16	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-16	colorectal cancer	down	Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-16	esophageal squamous cell carcinoma	up	Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-16	head and neck squamous cell carcinoma	up	Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-16	hepatocellular carcinoma	down	Circulating microRNAs as biomarkers for hepatocellular carcinoma.
hsa-mir-16	laryngeal carcinoma	up	MicroRNA-16 targets zyxin and promotes cell motility in human laryngeal carcinoma cell line HEp-2.
hsa-mir-16	osteosarcoma	down	MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-16	osteosarcoma	down	miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma.
hsa-mir-16	pancreatic ductal adenocarcinoma	down	MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors.
hsa-mir-16	squamous carcinoma	down	miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
hsa-mir-17	acute myeloid leukemia	down	HIF-1? downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation.
hsa-mir-17	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-17	colorectal carcinoma	up	Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma.
hsa-mir-17	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-17	glioma	up	Increased expression of microRNA-17 predicts poor prognosis in human glioma.
hsa-mir-17	glioma	up	Identification and functional characterization of microRNAs involved in the malignant progression of gliomas.
hsa-mir-17	medulloblastoma	up	The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-17	nasopharyngeal cancer	up	Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.
hsa-mir-17-5p	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-17-5p	breast cancer	down	Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.
hsa-mir-17-5p	breast cancer	up	miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1.
hsa-mir-17-5p	cervical cancer	down	MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells.
hsa-mir-17-5p	gastric cancer	up	Circulating microRNAs in plasma of patients with gastric cancers.
hsa-mir-17-5p	gastric cancer	up	Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.
hsa-mir-17-5p	hepatocellular carcinoma	up	miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway.
hsa-mir-17-5p	hepatocellular carcinoma	up	miR-17-5p as a novel prognostic marker for hepatocellular carcinoma.
hsa-mir-17-5p	malignant melanoma	up	Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-17-5p	malignant melanoma	up	Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-17-5p	non-small cell lung cancer	down	Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-17-5p	pancreatic cancer	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-17-5p	pancreatic cancer	up	MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
hsa-mir-17-5p	pancreatic cancer	up	miR-17-5p Inhibitor Enhances Chemosensitivity to Gemcitabine Via Upregulating Bim Expression in Pancreatic Cancer Cells.
hsa-mir-181a	acute myeloid leukemia	down	MicroRNA 181a Influences the Expression of HMGB1 and CD4 in Acute Leukemias.
hsa-mir-181a	breast cancer	up	Transforming growth factor-? regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM.
hsa-mir-181a	breast cancer	down	Decreased serum miR-181a is a potential new tool for breast cancer screening.
hsa-mir-181a	chronic lymphocytic leukemia	down	Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
hsa-mir-181a	chronic lymphocytic leukemia	down	miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
hsa-mir-181a	gastric cancer	up	MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6.
hsa-mir-181a	gastric cancer	up	Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.
hsa-mir-181a	glioma	down	hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells.
hsa-mir-181a	oral squamous cell carcinoma	down	miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras.
hsa-mir-181a	osteosarcoma	up	MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-181a	osteosarcoma	up	MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell.
hsa-mir-181a-2*	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-181b	breast cancer	up	Transforming growth factor-? regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM.
hsa-mir-181b	chronic lymphocytic leukemia	down	Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
hsa-mir-181b	chronic lymphocytic leukemia	down	miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
hsa-mir-181b	gastric adenocarcinoma	down	MicroRNA-181b targets cAMP responsive element binding protein 1 in gastric adenocarcinomas.
hsa-mir-181b	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-181b	glioma	down	hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells.
hsa-mir-181b	glioma	down	MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas.
hsa-mir-181b	osteosarcoma	up	MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-181b	prostate cancer	up	MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3.
hsa-mir-181c	osteosarcoma	up	MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-181d	glioma	down	MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2.
hsa-mir-182	bladder cancer	up	Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.
hsa-mir-182	breast cancer	up	Up-regulation of miR-182 by ?-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK.
hsa-mir-182	breast cancer	up	Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
hsa-mir-182	colorectal cancer	up	Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value.
hsa-mir-182	gastric adenocarcinoma	down	MicroRNA-182 targets cAMP-responsive element-binding protein?1 and suppresses cell growth in human gastric adenocarcinoma.
hsa-mir-182	glioma	up	The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas.
hsa-mir-182	glioma	up	miR-182 as a prognostic marker for glioma progression and patient survival.
hsa-mir-182	hepatocellular carcinoma	up	MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma.
hsa-mir-182	lung cancer	up	Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia.
hsa-mir-182	malignant melanoma	up	Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor.
hsa-mir-182	ovarian cancer	up	The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimul
hsa-mir-182	ovarian carcinoma	up	MicroRNA-182 promotes cell growth, invasion and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.
hsa-mir-182	prostate cancer	up	miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells.
hsa-mir-182	uveal melanoma	down	Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2.
hsa-mir-182-5p	bladder cancer	up	Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.
hsa-mir-182-5p	prostate cancer	up	MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer.
hsa-mir-1826	breast cancer	down	MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer.
hsa-mir-1826	kidney cancer	down	MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.
hsa-mir-183	bladder cancer	up	Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.
hsa-mir-183	bladder cancer	up	MicroRNA expression signatures of bladder cancer revealed by deep sequencing.
hsa-mir-183	breast cancer	down	Dysregulated miR-183 inhibits migration in breast cancer cells.
hsa-mir-183	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-183	glioma	up	The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas.
hsa-mir-183	hepatocellular carcinoma	up	miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells.
hsa-mir-183	medullary thyroid carcinoma	up	MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.
hsa-mir-183	osteosarcoma	down	Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
hsa-mir-183	prostate cancer	up	miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells.
hsa-mir-183	prostate cancer	up	microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer.
hsa-mir-184	glioma	down	Identification and functional characterization of microRNAs involved in the malignant progression of gliomas.
hsa-mir-184	malignant melanoma	down	Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-184	neuroblastoma	down	MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2.
hsa-mir-184	neuroblastoma	down	MicroRNA-184-mediated inhibition of tumour growth in an orthotopic murine model of neuroblastoma.
hsa-mir-185	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-185	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-185	glioma	down	LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway.
hsa-mir-185	malignant melanoma	down	Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-186	colon carcinoma	down	[Expression of hsa-miR-186 and its role in human colon carcinoma cells].
hsa-mir-186	non-small cell lung cancer	down	miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation.
hsa-mir-18a	bladder cancer	down	microRNA-18a, a member of the oncogenic miR-17-92 cluster, targets Dicer and suppresses cell proliferation in bladder cancer T24 cells.
hsa-mir-18a	colon cancer	up	MicroRNA-18a Attenuates DNA Damage Repair through Suppressing the Expression of Ataxia Telangiectasia Mutated in Colorectal Cancer.
hsa-mir-18a	colorectal cancer	up	microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers.
hsa-mir-18a	esophageal squamous cell carcinoma	up	Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma.
hsa-mir-18a	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-18a	malignant melanoma	up	Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-18a	medulloblastoma	up	The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-18a	nasopharyngeal carcinoma	up	miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
hsa-mir-18a	non-small cell lung cancer	up	Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC.
hsa-mir-18a	pancreatic cancer	up	Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer.
hsa-mir-18a	pancreatic ductal adenocarcinoma	up	Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-191	breast cancer	up	Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.
hsa-mir-191	breast cancer	down	Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.
hsa-mir-191	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-191	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-191	hepatocellular carcinoma	up	Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma.
hsa-mir-191	osteosarcoma	up	MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
hsa-mir-192	bladder cancer	down	Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-192	colon cancer	down	Prognostic significance of miR-215 in colon cancer.
hsa-mir-192	colorectal cancer	down	microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.
hsa-mir-192	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-192	gastric cancer	up	MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro.
hsa-mir-192	lung cancer	down	MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells.
hsa-mir-192	pancreatic ductal adenocarcinoma	up	Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma.
hsa-mir-193a-3p	breast cancer	down	Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer.
hsa-mir-193b	breast cancer	down	Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
hsa-mir-193b	malignant melanoma	up	miR-193b Regulates Mcl-1 in Melanoma.
hsa-mir-193b	malignant melanoma	down	Stathmin 1 is a potential novel oncogene in melanoma.
hsa-mir-193b	non-small cell lung cancer	down	MicroRNA-193b modulates proliferation, migration, and invasion of non-small cell lung cancer cells.
hsa-mir-193b	primary cns lymphomas	down	Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
hsa-mir-194	colorectal cancer	down	microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.
hsa-mir-194	lung cancer	down	miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27(kip1.)
hsa-mir-195	adrenal cortical carcinoma	down	The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-195	adrenal cortical carcinoma	down	miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer.
hsa-mir-195	bladder cancer	down	Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells.
hsa-mir-195	breast cancer	down	Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer.
hsa-mir-195	breast cancer	down	Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
hsa-mir-195	colorectal cancer	down	microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells.
hsa-mir-195	colorectal cancer	down	Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-195	gastric cancer	down	MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer.
hsa-mir-195	glioblastoma	down	MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion.
hsa-mir-195	hepatocellular carcinoma	down	MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2 and CDC42.
hsa-mir-196a	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-196a	esophageal adenocarcinoma	up	MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.
hsa-mir-196a	gastric cancer	up	MiR-196a Is Up-regulated in Gastric cancer and Promotes Cell proliferation by Down-regulating p27kip1.
hsa-mir-196a	gastrointestinal stromal tumor	up	Upregulation of miR-196a and HOTAIR Drive Malignant Character in Gastrointestinal Stromal Tumors.
hsa-mir-196a	non-small cell lung cancer	up	MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.
hsa-mir-196a	squamous carcinoma	up	Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-196a*	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-196b	gastric cancer	up	Epigenetic regulation of miR-196b expression in gastric cancer.
hsa-mir-196b	gastric cancer	up	Transcriptional regulation of miR-196b by ETS2 in gastric cancer cells.
hsa-mir-196b	glioblastoma	up	Upregulation of miR-196b confers a poor prognosis in glioblastoma patients via inducing a proliferative phenotype.
hsa-mir-197	follicular thyroid carcinoma	up	A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.
hsa-mir-197	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-197	lung cancer	up	Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia.
hsa-mir-1974	adrenal cortical carcinoma	down	The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-198	hepatocellular carcinoma	down	miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.
hsa-mir-199a	gastric cancer	up	miR-199a regulates the tumor suppressor mitogen-activated protein kinase kinase kinase 11 in gastric cancer.
hsa-mir-199a	hepatocellular carcinoma	down	[MicroRNA profiling in patients with hepatocellular carcinoma].
hsa-mir-199a	hepatocellular carcinoma	down	Circulating microRNAs as biomarkers for hepatocellular carcinoma.
hsa-mir-199a	hepatocellular carcinoma	down	Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.
hsa-mir-199a	kidney cancer	down	Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3?.
hsa-mir-199a	ovarian cancer	down	Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis.
hsa-mir-199a	primary cns lymphomas	down	Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
hsa-mir-199a-3p	esophageal adenocarcinoma	up	MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1.
hsa-mir-199a-3p	osteosarcoma	down	MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
hsa-mir-199a-3p	osteosarcoma	down	A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.
hsa-mir-199a-5p	colorectal cancer	down	The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
hsa-mir-199a-5p	esophageal adenocarcinoma	up	MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1.
hsa-mir-199a-5p	hepatocellular carcinoma	down	Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.
hsa-mir-199b	choriocarcinoma	down	Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma.
hsa-mir-199b	hepatocellular carcinoma	down	[MicroRNA profiling in patients with hepatocellular carcinoma].
hsa-mir-199b	hepatocellular carcinoma	down	Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1? in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
hsa-mir-199b	prostate cancer	down	MiR199b Suppresses Expression of Hypoxia-Inducible Factor 1? (HIF-1?) in Prostate Cancer Cells.
hsa-mir-199b-3p	esophageal adenocarcinoma	up	MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1.
hsa-mir-199b-5p	breast cancer	down	MiR-199b-5p targets HER2 in breast cancer cells.
hsa-mir-199b-5p	medulloblastoma	down	The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.
hsa-mir-19a	cervical cancer	up	MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5.
hsa-mir-19a	gastric cancer	up	MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN.
hsa-mir-19a	gastric cancer	up	miR-19a Promotes Cell Growth and Tumorigenesis through Targeting SOCS1 in Gastric Cancer.
hsa-mir-19a	medulloblastoma	up	The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-19a	non-small cell lung cancer	up	Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.
hsa-mir-19b	cervical cancer	up	MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5.
hsa-mir-19b	gastric cancer	up	MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN.
hsa-mir-200a	esophageal adenocarcinoma	up	Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.
hsa-mir-200a	gastric adenocarcinoma	down	Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/?-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
hsa-mir-200a	gastric adenocarcinoma	down	Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.
hsa-mir-200a	hepatocellular carcinoma	down	The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma.
hsa-mir-200a	meningioma	down	Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.
hsa-mir-200b	gastric cancer	up	MicroRNA-200b Regulates Cell Proliferation, Invasion, and Migration by Directly Targeting ZEB2 in Gastric Carcinoma.
hsa-mir-200b	tongue cancer	down	MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
hsa-mir-200c	colon cancer	down	miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.
hsa-mir-200c	colorectal cancer	down	miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.
hsa-mir-200c	colorectal cancer	up	MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
hsa-mir-200c	head and neck squamous cell carcinoma	down	MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
hsa-mir-200c	hepatocellular carcinoma	down	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-200c	malignant melanoma	down	Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.
hsa-mir-200c	malignant melanoma	down	miR-200c Inhibits Melanoma Progression and Drug Resistance through Down-Regulation of Bmi-1.
hsa-mir-200c	non-small cell lung cancer	up	High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
hsa-mir-200c	ovarian cancer	down	Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel.
hsa-mir-200c	rectal cancer	up	The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer.
hsa-mir-200c	renal clear cell carcinoma	down	Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
hsa-mir-200c	renal clear cell carcinoma	down	miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-203	bladder cancer	down	microRNA-203 suppresses bladder cancer development by repressing bcl-w expression.
hsa-mir-203	bladder cancer	down	Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer.
hsa-mir-203	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-203	breast cancer	up	Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin Chemosensitivity.
hsa-mir-203	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-203	esophageal adenocarcinoma	down	Deciphering the Unique MicroRNA Signature in Human Esophageal Adenocarcinoma.
hsa-mir-203	esophageal squamous cell carcinoma	down	MicroRNA-203 inhibits cell proliferation by repressing ?Np63 expression in human esophageal squamous cell carcinoma.
hsa-mir-203	hepatocellular carcinoma	down	miR-203 inhibits proliferation of HCC cells by targeting survivin.
hsa-mir-203	lung cancer	down	The expression and function of microRNA-203 in lung cancer.
hsa-mir-203	malignant melanoma	down	Anti-oncogenic MicroRNA-203 Induces Senescence by Targeting E2F3 in Human Melanoma Cells.
hsa-mir-203	pancreatic adenocarcinoma	up	MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.
hsa-mir-203	pancreatic ductal adenocarcinoma	up	Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-203	squamous carcinoma	down	MicroRNA expression profiles of esophageal cancer.
hsa-mir-203	squamous carcinoma	up	Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-204	gastric cancer	down	MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells.
hsa-mir-204	glioma	down	Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype.
hsa-mir-204	malignant melanoma	down	Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-204	prostate cancer	up	Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.
hsa-mir-204	renal clear cell carcinoma	down	VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma.
hsa-mir-205	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-205	bladder cancer	down	Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-205	breast cancer	down	Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-205	breast cancer	down	Suppression of cell growth and invasion by miR-205 in breast cancer.
hsa-mir-205	cervical cancer	up	miR-205 Expression Promotes Cell Proliferation and Migration of Human Cervical Cancer Cells.
hsa-mir-205	cervical squamous cell carcinoma	up	miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes.
hsa-mir-205	glioma	down	MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A.
hsa-mir-205	glioma	down	Identification of microRNA-205 as a potential prognostic indicator for human glioma.
hsa-mir-205	head and neck squamous cell carcinoma	down	Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
hsa-mir-205	kidney cancer	down	MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.
hsa-mir-205	lung cancer	up	Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.
hsa-mir-205	malignant melanoma	down	miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein.
hsa-mir-205	malignant melanoma	down	Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.
hsa-mir-205	malignant melanoma	down	Chemically Modified Synthetic microRNA-205 Inhibits the Growth of Melanoma Cells In Vitro and In Vivo.
hsa-mir-205	prostate cancer	down	MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer.
hsa-mir-205	prostate cancer	down	Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer.
hsa-mir-205	squamous carcinoma	down	MicroRNA expression profiles of esophageal cancer.
hsa-mir-206	breast cancer	down	miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2.
hsa-mir-206	gastric cancer	down	MiR-206 inhibits gastric cancer proliferation in part by repressing CyclinD2.
hsa-mir-206	gastric cancer	down	Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
hsa-mir-206	laryngeal squamous cell carcinoma	down	Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
hsa-mir-20a	acute myeloid leukemia	down	HIF-1? downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation.
hsa-mir-20a	breast cancer	up	Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.
hsa-mir-20a	cervical cancer	up	miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells.
hsa-mir-20a	colorectal cancer	up	MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-20a	glioma	up	[Expression of hsa-miR-20a in human glioma tissues and its effect on the proliferation of human glioma cells in vitro].
hsa-mir-20a	hepatocellular carcinoma	down	Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma.
hsa-mir-20a	malignant melanoma	up	Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-20a	medulloblastoma	up	The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-20a	nasopharyngeal cancer	up	Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.
hsa-mir-20a	ovarian cancer	up	miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells.
hsa-mir-21	adrenal cortical carcinoma	up	The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-21	breast cancer	up	Next-generation sequencing of microRNAs for breast cancer detection.
hsa-mir-21	breast cancer	up	Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.
hsa-mir-21	breast cancer	up	Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.
hsa-mir-21	breast cancer	up	Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.
hsa-mir-21	breast cancer	up	BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1.
hsa-mir-21	breast cancer	up	Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion.
hsa-mir-21	breast cancer	up	MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression.
hsa-mir-21	cervical carcinoma	up	MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.
hsa-mir-21	cholangiocarcinoma	up	MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.
hsa-mir-21	cholangiocarcinoma	up	PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma.
hsa-mir-21	colorectal cancer	up	Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells.
hsa-mir-21	colorectal cancer	up	Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.
hsa-mir-21	colorectal cancer	up	MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
hsa-mir-21	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-21	colorectal cancer	up	Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.
hsa-mir-21	colorectal cancer	up	Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer.
hsa-mir-21	colorectal carcinoma	up	Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
hsa-mir-21	diffuse large B-cell lymphoma	up	Inhibition of miR-21 Induces Biological and Behavioral Alterations in Diffuse Large B-Cell Lymphoma.
hsa-mir-21	endometrial cancer	up	Highly increased maspin expression corresponds with up-regulation of miR-21 in endometrial cancer: a preliminary report.
hsa-mir-21	esophageal squamous cell carcinoma	up	miR-21 Down-Regulation Suppresses Cell Growth, Invasion and Induces Cell Apoptosis by Targeting FASL, TIMP3, and RECK Genes in Esophageal Carcinoma.
hsa-mir-21	esophageal squamous cell carcinoma	up	MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway.
hsa-mir-21	esophageal squamous cell carcinoma	up	Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-21	esophageal squamous cell carcinoma	up	Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.
hsa-mir-21	esophageal squamous cell carcinoma	down	Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma.
hsa-mir-21	esophageal squamous cell carcinoma	up	Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma.
hsa-mir-21	gastric cancer	up	microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN.
hsa-mir-21	gastric cancer	up	MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer.
hsa-mir-21	gastric cancer	up	miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer.
hsa-mir-21	gastric cancer	up	Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
hsa-mir-21	gastric cancer	up	miR-21 plays a pivotal role in gastric cancer pathogenesis and progression.
hsa-mir-21	gastric cancer	up	Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.
hsa-mir-21	gastric cancer	up	Circulating microRNAs in plasma of patients with gastric cancers.
hsa-mir-21	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-21	glioblastoma	up	PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.
hsa-mir-21	glioblastoma	up	MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme.
hsa-mir-21	glioblastoma	up	Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status.
hsa-mir-21	glioblastoma	up	Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro.
hsa-mir-21	glioblastoma	up	Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo.
hsa-mir-21	glioblastoma	down	MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide.
hsa-mir-21	glioblastoma	up	MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators.
hsa-mir-21	glioblastoma	up	Heterogeneous Nuclear Ribonucleoprotein C1/C2 Controls the Metastatic Potential of Glioblastoma by Regulating PDCD4.
hsa-mir-21	glioblastoma	up	MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells.
hsa-mir-21	head and neck cancer	up	MicroRNA alterations in head and neck squamous cell carcinoma.
hsa-mir-21	head and neck cancer	up	[Expression of mir-21 and mir-375 in laryngeal squamous cell carcinoma].
hsa-mir-21	head and neck squamous cell carcinoma	up	Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
hsa-mir-21	head and neck squamous cell carcinoma	up	Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-21	hepatocellular carcinoma	up	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-21	hepatocellular carcinoma	up	miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma.
hsa-mir-21	hepatocellular carcinoma	up	MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.
hsa-mir-21	hepatocellular carcinoma	up	Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
hsa-mir-21	hypopharyngeal squamous cell carcinoma	up	Altered Expression of miR-21 and PTEN in Human Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.
hsa-mir-21	kidney cancer	up	miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer.
hsa-mir-21	laryngeal carcinoma	up	Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
hsa-mir-21	laryngeal squamous cell carcinoma	up	Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma.
hsa-mir-21	laryngeal squamous cell carcinoma	up	Altered Expression of miR-21 and PTEN in Human Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.
hsa-mir-21	liver cancer	up	microRNA 21-mediated suppression of Sprouty1 by Pokemon affects liver cancer cell growth and proliferation.
hsa-mir-21	lung cancer	up	Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.
hsa-mir-21	lung cancer	up	Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia.
hsa-mir-21	malignant melanoma	up	microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells.
hsa-mir-21	non-small cell lung cancer	up	Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
hsa-mir-21	non-small cell lung cancer	up	[Overexpression of miR-21 promotes proliferation and reduces apoptosis in non-small cell lung cancer].
hsa-mir-21	non-small cell lung cancer	up	Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.
hsa-mir-21	non-small cell lung cancer	up	Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
hsa-mir-21	non-small cell lung cancer	up	High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
hsa-mir-21	non-small cell lung cancer	up	Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer.
hsa-mir-21	osteosarcoma	up	MicroRNA-21 is involved in osteosarcoma cell invasion and migration.
hsa-mir-21	osteosarcoma	up	A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.
hsa-mir-21	osteosarcoma	up	Identification of Serum MicroRNA-21 as a Biomarker for Chemosensitivity and Prognosis in Human Osteosarcoma.
hsa-mir-21	pancreatic cancer	up	MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival.
hsa-mir-21	pancreatic cancer	up	MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance.
hsa-mir-21	pancreatic ductal adenocarcinoma	up	Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.
hsa-mir-21	pancreatic ductal adenocarcinoma	up	Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.
hsa-mir-21	pancreatic ductal adenocarcinoma	up	MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.
hsa-mir-21	renal cell carcinoma	up	The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma.
hsa-mir-21	renal cell carcinoma	up	miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer.
hsa-mir-21	renal cell carcinoma	up	MicroRNA-21 is overexpressed in renal cell carcinoma.
hsa-mir-21	squamous carcinoma	up	Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-210	adrenal cortical carcinoma	up	The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-210	bladder cancer	up	Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.
hsa-mir-210	esophageal squamous cell carcinoma	down	MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1).
hsa-mir-210	esophageal squamous cell carcinoma	down	The Role of MicroRNA-210 in Esophageal Squamous Cell Carcinoma.
hsa-mir-210	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-210	hepatocellular carcinoma	up	Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma.
hsa-mir-210	kidney cancer	up	miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.
hsa-mir-210	lung cancer	up	MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines.
hsa-mir-210	malignant melanoma	up	MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
hsa-mir-210	osteosarcoma	up	Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma.
hsa-mir-210	renal cell carcinoma	up	MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.
hsa-mir-210	renal clear cell carcinoma	up	Overexpression of miR-210, a downstream target of HIF1?, causes centrosome amplification in renal carcinoma cells.
hsa-mir-210	renal clear cell carcinoma	up	miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-211	colorectal cancer	up	MicroRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5.
hsa-mir-211	malignant melanoma	down	The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.
hsa-mir-211	malignant melanoma	down	Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma.
hsa-mir-211	malignant melanoma	down	Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.
hsa-mir-211	malignant melanoma	down	Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.
hsa-mir-212	colorectal cancer	down	Genetic and Epigenetic Down-regulation of MicroRNA-212 Promotes Colorectal Tumor Metastasis via Dysregulation of MnSOD.
hsa-mir-212	gastric cancer	down	Down-regulation of miR-212 expression by DNA hypermethylation in human gastric cancer cells.
hsa-mir-212	gastric cancer	down	miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer.
hsa-mir-212	non-small cell lung cancer	down	miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.
hsa-mir-212	non-small cell lung cancer	up	MiR-212 displays Tumor Promoting properties in NSCLC Cells and targets the Hedgehog Pathway Receptor PTCH1.
hsa-mir-212	pancreatic cancer	up	miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.
hsa-mir-214	cervical cancer	down	MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-?-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7.
hsa-mir-214	cervical cancer	down	MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells.
hsa-mir-214	cervical squamous cell carcinoma	down	Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.
hsa-mir-214	esophageal squamous cell carcinoma	down	MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.
hsa-mir-214	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-214	gastric cancer	up	Down-regulated miRNA-214 induces a cell cycle G1 arrest in gastric cancer cells by up-regulating the PTEN protein.
hsa-mir-214	hepatocellular carcinoma	up	MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines.
hsa-mir-214	hepatocellular carcinoma	down	MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of ?-catenin.
hsa-mir-214	multiple myeloma	down	Restoration of miR-214 expression reduces growth of myeloma cells through a positive regulation of P53 and inhibition of DNA replication.
hsa-mir-214	nasopharyngeal carcinoma	up	miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.
hsa-mir-214	pancreatic cancer	down	Dysregulation of miR-15a and miR-214 in human pancreatic cancer.
hsa-mir-214	pancreatic cancer	up	Dysregulation of miR-15a and miR-214 in human pancreatic cancer.
hsa-mir-214	primary cns lymphomas	down	Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
hsa-mir-215	colon cancer	down	Prognostic significance of miR-215 in colon cancer.
hsa-mir-215	colorectal cancer	down	Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
hsa-mir-215	colorectal cancer	down	microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.
hsa-mir-215	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-215	gastric cancer	up	MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro.
hsa-mir-215	hepatocellular carcinoma	up	Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
hsa-mir-216a	hepatocellular carcinoma	up	Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis.
hsa-mir-216a	hepatocellular carcinoma	up	MiR-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
hsa-mir-216a	pancreatic cancer	down	[Expression of miR-216a in pancreatic cancer and its clinical significance].
hsa-mir-216b	nasopharyngeal carcinoma	down	miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma.
hsa-mir-217	hepatocellular carcinoma	up	MiR-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
hsa-mir-217	pancreatic ductal adenocarcinoma	down	The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.
hsa-mir-218	cervical cancer	down	Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion.
hsa-mir-218	cervical squamous cell carcinoma	down	Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma.
hsa-mir-218	colorectal cancer	down	MicroRNA-218 Inhibits Cell Cycle Progression and Promotes Apoptosis in Colon Cancer by Downregulating BMI1 Polycomb Ring Finger Oncogene.
hsa-mir-218	gastric cancer	down	Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
hsa-mir-218	gastric cancer	down	Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.
hsa-mir-218	gastric cancer	down	[Reduced expression of miR-218 and its significance in gastric cancer].
hsa-mir-218	head and neck squamous cell carcinoma	down	Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma.
hsa-mir-218	lung cancer	down	MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma.
hsa-mir-218	lung squamous cell carcinoma	down	MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma.
hsa-mir-218	nasopharyngeal cancer	down	MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway.
hsa-mir-218	oral cancer	down	The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer.
hsa-mir-218	pancreatic ductal adenocarcinoma	down	Enhancer of Zeste Homolog 2 Silences miR-218 in Human Pancreatic Ductal Adenocarcinoma Cells by Inducing Formation of Heterochromatin.
hsa-mir-218	renal cell carcinoma	down	MicroRNA-218 Inhibits Cell Migration and Invasion in Renal Cell Carcinoma Through Targeting Caveolin-2 Involved in Focal Adhesion Pathway.
hsa-mir-218	renal clear cell carcinoma	down	miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-219-5p	glioblastoma	down	miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma.
hsa-mir-219-5p	glioma	down	miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma.
hsa-mir-219-5p	hepatocellular carcinoma	down	MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
hsa-mir-22	colon cancer	down	MicroRNA-22 regulates hypoxia signaling in colon cancer cells.
hsa-mir-22	colon cancer	down	MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells.
hsa-mir-22	colon cancer	down	miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9.
hsa-mir-22	colorectal cancer	down	Clinical significance of miR-22 expression in patients with colorectal cancer.
hsa-mir-22	esophageal squamous cell carcinoma	down	Increased miRNA-22 expression sensitizes esophageal squamous cell carcinoma to irradiation.
hsa-mir-22	gastric cancer	down	miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1.
hsa-mir-22	hepatocellular carcinoma	down	MicroRNA-22 expression in hepatocellular carcinoma and its correlation with ezrin protein.
hsa-mir-22	hepatocellular carcinoma	down	microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity.
hsa-mir-22	lung cancer	down	Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3.
hsa-mir-22	t-cell lymphoma	down	miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9.
hsa-mir-221	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-221	bladder cancer	up	MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL.
hsa-mir-221	colon carcinoma	up	[MicroRNA-221 promotes colon carcinoma cell proliferation in vitro by inhibiting CDKN1C/p57 expression].
hsa-mir-221	colorectal cancer	up	MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma.
hsa-mir-221	colorectal cancer	up	[MicroRNA-221 controls CDKN1C/P57 expression in human colorectal carcinoma].
hsa-mir-221	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-221	gastric cancer	up	Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance.
hsa-mir-221	gastrointestinal stromal tumor	down	Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.
hsa-mir-221	glioma	up	MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma.
hsa-mir-221	hepatocellular carcinoma	up	MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
hsa-mir-221	hepatocellular carcinoma	up	miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
hsa-mir-221	hepatocellular carcinoma	up	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-221	hepatocellular carcinoma	up	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-mir-221	hepatocellular carcinoma	up	Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.
hsa-mir-221	non-small cell lung cancer	up	miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
hsa-mir-221	non-small cell lung cancer	down	Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-221	oral squamous cell carcinoma	up	miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells.
hsa-mir-221	osteosarcoma	up	MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma.
hsa-mir-221	papillary thyroid carcinoma	up	MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
hsa-mir-221	squamous carcinoma	up	Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-221	thyroid carcinoma	up	MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.
hsa-mir-221*	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-222	breast cancer	up	Analysis of serum genome-wide microRNAs for breast cancer detection.
hsa-mir-222	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-222	gastric cancer	up	Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK.
hsa-mir-222	gastrointestinal stromal tumor	down	Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.
hsa-mir-222	glioma	up	MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma.
hsa-mir-222	hepatocellular carcinoma	up	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-222	hepatocellular carcinoma	up	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-mir-222	hepatocellular carcinoma	up	miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
hsa-mir-222	non-small cell lung cancer	up	miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
hsa-mir-222	non-small cell lung cancer	up	Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.
hsa-mir-222	oral squamous cell carcinoma	up	miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells.
hsa-mir-222	papillary thyroid carcinoma	up	MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
hsa-mir-222	thyroid carcinoma	up	MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.
hsa-mir-223	acute myeloid leukemia	down	Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia.
hsa-mir-223	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-223	chronic lymphocytic leukemia	down	MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.
hsa-mir-223	chronic lymphocytic leukemia	down	[Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders].
hsa-mir-223	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-223	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-223	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-223	gastric cancer	up	MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4.
hsa-mir-223	gastric cancer	up	Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
hsa-mir-223	hepatocellular carcinoma	up	Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
hsa-mir-223	hepatocellular carcinoma	down	[Role of microRNA-223 and its target gene oncogene c-myc in hepatocellular carcinoma pathogenesis.]
hsa-mir-223	hepatocellular carcinoma	down	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-223	mantle cell lymphoma	down	MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.
hsa-mir-223	mantle cell lymphoma	down	[Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders].
hsa-mir-223	nasopharyngeal cancer	down	Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.
hsa-mir-223	splenic marginal zone lymphoma	down	MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.
hsa-mir-223	splenic marginal zone lymphoma	down	[Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders].
hsa-mir-224	breast cancer	up	MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells.
hsa-mir-224	cervical cancer	up	Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer.
hsa-mir-224	glioma	up	Upregulation of microRNA-224 confers a poor prognosis in glioma patients.
hsa-mir-224	hepatocellular carcinoma	up	Transcriptional regulation of miR-224 upregulated in human HCCs by NF?B inflammatory pathways.
hsa-mir-224	hepatocellular carcinoma	up	Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis.
hsa-mir-224	hepatocellular carcinoma	up	MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms.
hsa-mir-224	hepatocellular carcinoma	up	Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
hsa-mir-23a	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-23a	breast cancer	up	c-MYC regulated miR-23a~24-2~27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2.
hsa-mir-23a	colon carcinoma	up	[Expression and clinical significance of miR-23a and metastasis suppressor 1 in colon carcinoma].
hsa-mir-23a	gastric adenocarcinoma	up	MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor.
hsa-mir-23a	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-23a	gastric cancer	up	MiR-23a in Amplified 19p13.13 Loci Targets Metallothionein 2A and Promotes Growth in Gastric Cancer Cells.
hsa-mir-23a	hepatocellular carcinoma	up	Stat3-mediated activation of miR-23a suppresses gluconeogenesis in hepatocellular carcinoma by downregulating G6PC and PGC-1?
hsa-mir-23b	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-23b	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-23b	glioma	down	miRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2.
hsa-mir-23b	ovarian cancer	up	MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-24	breast carcinoma	up	MicroRNA miR-24 Enhances Tumor Invasion and Metastasis by Targeting PTPN9 and PTPRF to Promote EGF Signaling.
hsa-mir-24	glioma	up	MiR-24 regulates the proliferation and invasion of glioma by ST7L via ?-catenin/Tcf-4 signaling.
hsa-mir-24	laryngeal squamous cell carcinoma	down	miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein.
hsa-mir-24	lung cancer	up	Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.
hsa-mir-24	oral squamous cell carcinoma	up	miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.
hsa-mir-24	osteosarcoma	down	MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAAT?.
hsa-mir-24-3p	glioma	up	miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1.
hsa-mir-25	colon cancer	down	MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7.
hsa-mir-25	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-25	esophageal squamous cell carcinoma	up	MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma.
hsa-mir-25	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-25	ovarian cancer	up	MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer.
hsa-mir-26a	acute myeloid leukemia	down	Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2.
hsa-mir-26a	breast cancer	down	Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer.
hsa-mir-26a	breast cancer	down	MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1.
hsa-mir-26a	cholangiocarcinoma	up	MicroRNA-26a promotes cholangiocarcinoma growth by activating ?-catenin.
hsa-mir-26a	hepatocellular carcinoma	down	Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways.
hsa-mir-26a	hepatocellular carcinoma	down	IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells.
hsa-mir-26a	hepatocellular carcinoma	down	MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting IL-6-Stat3 pathway.
hsa-mir-26a	malignant melanoma	down	MicroRNA-26a Is Strongly Downregulated in Melanoma and Induces Cell Death through Repression of Silencer of Death Domains (SODD).
hsa-mir-26a	prostate cancer	down	Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms.
hsa-mir-26b	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-26b	breast cancer	down	MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11.
hsa-mir-26b	breast cancer	down	MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer.
hsa-mir-26b	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-26b	glioma	down	Role of microRNA-26b in glioma development and its mediated regulation on EphA2.
hsa-mir-26b	prostate cancer	down	Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms.
hsa-mir-27a	acute leukemia	down	MiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3-3?.
hsa-mir-27a	breast cancer	up	c-MYC regulated miR-23a~24-2~27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2.
hsa-mir-27a	gastric adenocarcinoma	up	MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin.
hsa-mir-27a	gastric cancer	up	Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells.
hsa-mir-27a	non-small cell lung cancer	down	Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-27a	ovarian cancer	up	MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-27a	ovarian cancer	up	Oncogenic MicroRNA-27a is a Target for Genistein in Ovarian Cancer Cells.
hsa-mir-27a	small cell lung cancer	down	miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro.
hsa-mir-27a	squamous carcinoma	up	Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-27a-3p	glioma	up	miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1.
hsa-mir-27b	glioma	up	Expression and function of miR-27b in human glioma.
hsa-mir-27b	ovarian cancer	up	MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-28-3p	colorectal cancer	down	Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells.
hsa-mir-28-5p	colorectal cancer	down	Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells.
hsa-mir-296-5p	gastric cancer	up	MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1.
hsa-mir-29a	acute myeloid leukemia	down	MicroRNA29a regulates the expression of the nuclear oncogene Ski.
hsa-mir-29a	acute myeloid leukemia	up	microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia.
hsa-mir-29a	breast cancer	up	Next-generation sequencing of microRNAs for breast cancer detection.
hsa-mir-29a	colorectal cancer	up	microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers.
hsa-mir-29a	gastric cancer	down	MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer.
hsa-mir-29a	hepatocellular carcinoma	down	microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma.
hsa-mir-29a	mantle cell lymphoma	down	microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-29b	chronic lymphocytic leukemia	down	Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
hsa-mir-29b	glioblastoma	down	miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.
hsa-mir-29b	lung adenocarcinoma	down	MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma.
hsa-mir-29b	mantle cell lymphoma	down	microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-29b	non-small cell lung cancer	down	Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC.
hsa-mir-29b	osteosarcoma	down	MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-29b	prostate cancer	down	miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling.
hsa-mir-29c	esophageal squamous cell carcinoma	down	miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression.
hsa-mir-29c	gastric cancer	down	MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2.
hsa-mir-29c	gastric cancer	down	The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells.
hsa-mir-29c	hepatocellular carcinoma	down	MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma.
hsa-mir-29c	mantle cell lymphoma	down	microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-29c	nasopharyngeal cancer	down	Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.
hsa-mir-29c	nasopharyngeal carcinoma	down	MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma.
hsa-mir-29c	non-small cell lung cancer	up	Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-301a	gastric cancer	up	Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer.
hsa-mir-301a	hepatocellular carcinoma	up	miR-301a Is a Candidate Oncogene that Targets the Homeobox Gene Gax in Human Hepatocellular Carcinoma.
hsa-mir-301a	pancreatic adenocarcinoma	up	miR-301a as an NF-?B activator in pancreatic cancer cells.
hsa-mir-301a	pancreatic cancer	up	miR-301a promotes pancreatic cancer cell proliferation by directly inhibiting Bim expression.
hsa-mir-302f	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-30a	breast cancer	down	MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
hsa-mir-30a	breast cancer	down	Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.
hsa-mir-30a	colorectal carcinoma	down	miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma.
hsa-mir-30a	non-small cell lung cancer	down	MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.
hsa-mir-30a-3p	colorectal cancer	down	Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
hsa-mir-30a-5p	colon carcinoma	down	MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL.
hsa-mir-30a-5p	esophageal squamous cell carcinoma	up	Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-30a-5p	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-30a-5p	glioma	up	Analysis of hsa-miR-30a-5p Expression in Human Gliomas.
hsa-mir-30a-5p	head and neck squamous cell carcinoma	up	Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-30b	medulloblastoma	up	Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma.
hsa-mir-30b-5p	pancreatic ductal adenocarcinoma	up	Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-30c	endometrial cancer	down	microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1.
hsa-mir-30d	hepatocellular carcinoma	up	MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma.
hsa-mir-30d	lung cancer	up	Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.
hsa-mir-30d	medulloblastoma	up	Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma.
hsa-mir-30d	non-small cell lung cancer	down	Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
hsa-mir-30e*	glioma	up	MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-?B/I?B? negative feedback loop.
hsa-mir-30e-5p	non-small cell lung cancer	down	Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
hsa-mir-31	breast cancer	down	Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis.
hsa-mir-31	breast cancer	down	miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer.
hsa-mir-31	chronic myelogenous leukemia	down	Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
hsa-mir-31	colon cancer	up	The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer.
hsa-mir-31	colorectal cancer	up	Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer.
hsa-mir-31	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-31	colorectal cancer	up	MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-31	colorectal cancer	up	Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.
hsa-mir-31	esophageal squamous cell carcinoma	up	The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma.
hsa-mir-31	gastric cancer	down	Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance.
hsa-mir-31	glioblastoma	down	Human miR-31 targets radixin and inhibits migration and invasion of glioma cells.
hsa-mir-31	hepatocellular carcinoma	up	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-31	malignant melanoma	down	Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-31	malignant melanoma	down	Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma.
hsa-mir-31	non-small cell lung cancer	up	Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.
hsa-mir-31	oral carcinoma	up	Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma.
hsa-mir-31	oral carcinoma	up	Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
hsa-mir-31	pancreatic ductal adenocarcinoma	up	Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-32	acute myeloid leukemia	up	MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis.
hsa-mir-320a	colon cancer	down	MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting ?-catenin.
hsa-mir-320a	colorectal cancer	down	microRNA-320a inhibits tumor invasion by targeting neuropilin?1 and is associated with liver metastasis in colorectal cancer.
hsa-mir-324-3p	nasopharyngeal carcinoma	down	MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B.
hsa-mir-326	chronic myelogenous leukemia	down	Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34(+) CML stem/progenitor cells.
hsa-mir-326	glioblastoma	down	Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma.
hsa-mir-326	glioma	down	The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors.
hsa-mir-328	colorectal cancer	down	MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer.
hsa-mir-328	non-small cell lung cancer	up	Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC.
hsa-mir-330	prostate cancer	down	MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
hsa-mir-331-3p	gastric cancer	down	miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer.
hsa-mir-331-3p	prostate cancer	down	Regulation of Expression of Deoxyhypusine Hydroxylase (DOHH), the Enzyme That Catalyzes the Activation of eIF5A, by miR-331-3p and miR-642-5p in Prostate Cancer Cells.
hsa-mir-331-3p	prostate cancer	down	miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer.
hsa-mir-335	adrenal cortical carcinoma	down	miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer.
hsa-mir-335	astrocytoma	up	Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells.
hsa-mir-335	breast cancer	down	MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer.
hsa-mir-335	breast cancer	down	Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-335	glioma	up	Tumor microRNA-335 expression is associated with poor prognosis in human glioma.
hsa-mir-335	hepatocellular carcinoma	down	Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma.
hsa-mir-335	meningioma	up	miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas.
hsa-mir-335	neuroblastoma	down	MiRNA-335 Suppresses Neuroblastoma Cell Invasiveness By Direct Targeting of Multiple Genes from the non-Canonical TGF-? Signalling Pathway.
hsa-mir-335	non-small cell lung cancer	down	Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299.
hsa-mir-335	renal clear cell carcinoma	down	miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-337-3p	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-338-3p	hepatocellular carcinoma	down	miR-338-3p Is Down-Regulated by Hepatitis B Virus X and Inhibits Cell Proliferation by Targeting the 3'-UTR Region of CyclinD1.
hsa-mir-338-3p	liver cancer	down	miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened.
hsa-mir-339	non-small cell lung cancer	up	Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC.
hsa-mir-339-5p	breast cancer	down	MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis.
hsa-mir-340*	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-342	acute promyelocytic leukemia	down	A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.
hsa-mir-342	colorectal cancer	down	MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1.
hsa-mir-345	colorectal cancer	down	MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
hsa-mir-346	follicular thyroid carcinoma	up	A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.
hsa-mir-346	ovarian cancer	up	MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-34a	b-cell lymphoma	down	The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.
hsa-mir-34a	breast cancer	down	Circulating miR-34a levels are reduced in colorectal cancer.
hsa-mir-34a	breast cancer	down	Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion.
hsa-mir-34a	cervical carcinoma	down	MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.
hsa-mir-34a	choriocarcinoma	down	MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.
hsa-mir-34a	choriocarcinoma	down	MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.
hsa-mir-34a	colon cancer	down	Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF.
hsa-mir-34a	colon cancer	down	MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
hsa-mir-34a	colorectal cancer	down	Circulating miR-34a levels are reduced in colorectal cancer.
hsa-mir-34a	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-34a	gastric cancer	down	Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells.
hsa-mir-34a	glioblastoma	down	miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme.
hsa-mir-34a	glioblastoma	down	MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
hsa-mir-34a	glioblastoma	down	MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme.
hsa-mir-34a	glioma	down	MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
hsa-mir-34a	glioma	down	microRNA-34a is tumor suppressive in brain tumors and glioma stem cells.
hsa-mir-34a	head and neck squamous cell carcinoma	down	Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis.
hsa-mir-34a	hepatocellular carcinoma	down	miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
hsa-mir-34a	hepatocellular carcinoma	down	Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model.
hsa-mir-34a	hepatocellular carcinoma	down	Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET.
hsa-mir-34a	malignant melanoma	down	MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
hsa-mir-34a	malignant melanoma	down	Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-34a	malignant melanoma	down	Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene.
hsa-mir-34a	neuroblastoma	down	MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
hsa-mir-34a	neuroblastoma	down	A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.
hsa-mir-34a	osteosarcoma	down	MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo.
hsa-mir-34a	osteosarcoma	down	MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether  go-go 1 expression.
hsa-mir-34a	pancreatic cancer	down	Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells.
hsa-mir-34a	prostate cancer	down	The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
hsa-mir-34a	prostate cancer	down	MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells.
hsa-mir-34a	rectal cancer	up	The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer.
hsa-mir-34a	renal cell carcinoma	down	MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.
hsa-mir-34a	retinoblastoma	down	Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
hsa-mir-34a	squamous carcinoma	up	Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-34a	uveal melanoma	down	MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
hsa-mir-34b	endometrial serous adenocarcinoma	down	MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma.
hsa-mir-34b	gastric cancer	down	Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer.
hsa-mir-34b	non-small cell lung cancer	down	MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met.
hsa-mir-34b	ovarian carcinoma	down	MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
hsa-mir-34b	pancreatic cancer	down	MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3.
hsa-mir-34b	prostate cancer	down	miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.
hsa-mir-34b	uveal melanoma	down	MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.
hsa-mir-34c	colon cancer	down	Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF.
hsa-mir-34c	gastric cancer	down	Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
hsa-mir-34c	lung cancer	down	Uncovering growth-suppressive MicroRNAs in lung cancer.
hsa-mir-34c	malignant melanoma	down	Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene.
hsa-mir-34c	ovarian carcinoma	down	MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
hsa-mir-34c	prostate cancer	down	miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
hsa-mir-34c	uveal melanoma	down	MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.
hsa-mir-361-3p	non-small cell lung cancer	down	Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.
hsa-mir-363	head and neck squamous cell carcinoma	down	Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin.
hsa-mir-365	colon cancer	down	microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2.
hsa-mir-365	lung cancer	down	MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer.
hsa-mir-365b-3p	retinoblastoma	down	MiR-365b-3p, down-regulated in retinoblastoma, regulates cell cycle progression and apoptosis of human retinoblastoma cells by targeting PAX6.
hsa-mir-369-5p	pancreatic ductal adenocarcinoma	up	Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-370	acute myeloid leukemia	up	Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia.
hsa-mir-370	gastric cancer	up	Upregulation of miR-370 contributes to the progression of gastric carcinoma via suppression of FOXO1.
hsa-mir-370	gastric cancer	up	Overexpression of miR-370 and downregulation of its novel target TGF?-RII contribute to the progression of gastric carcinoma.
hsa-mir-370	hepatocellular carcinoma	down	Perturbation of miR-370-LIN28A-NF-?B regulatory circuit contributes to the development of hepatocellular carcinoma.
hsa-mir-370	oral squamous cell carcinoma	down	miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma.
hsa-mir-371-5p	hepatocellular carcinoma	up	miR-371-5p down-regulates pre mRNA processing factor 4 homolog B (PRPF4B) and facilitates the G1/S transition in human hepatocellular carcinoma cells.
hsa-mir-372	cervical cancer	down	MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.
hsa-mir-372	glioma	up	Correlation of microrna-372 upregulation with poor prognosis in human glioma.
hsa-mir-372	hepatocellular carcinoma	up	Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma.
hsa-mir-373	colon cancer	down	Epigenetic silencing of microRNA-373 plays an important role in regulating cell proliferation in colon cancer.
hsa-mir-373	esophageal squamous cell carcinoma	up	MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.
hsa-mir-373	hepatocellular carcinoma	up	MicroRNA-373, a new regulator of protein phosphatase?6, functions as an oncogene in hepatocellular carcinoma.
hsa-mir-374a	breast cancer	down	Effects of Differential Distribution of Microvessel Density, Possibly Regulated by miR-374a, on Breast Cancer Prognosis.
hsa-mir-375	cervical squamous cell carcinoma	down	miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1.
hsa-mir-375	colorectal cancer	down	Expression levels of microRNA-375 in colorectal carcinoma.
hsa-mir-375	colorectal cancer	down	Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
hsa-mir-375	esophageal cancer	down	Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer.
hsa-mir-375	esophageal squamous cell carcinoma	down	Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.
hsa-mir-375	esophageal squamous cell carcinoma	down	Cell-specific detection of miR-375 downregulation for predicting the prognosis of esophageal squamous cell carcinoma by miRNA in situ hybridization.
hsa-mir-375	gastric cancer	down	MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
hsa-mir-375	gastric cancer	down	MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.
hsa-mir-375	glioma	down	Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
hsa-mir-375	head and neck squamous cell carcinoma	down	Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.
hsa-mir-375	hepatocellular carcinoma	down	MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
hsa-mir-375	hepatocellular carcinoma	down	miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions.
hsa-mir-375	nasopharyngeal carcinoma	down	Significance of dysregulated metadherin and microRNA-375 in head and neck cancer.
hsa-mir-375	non-small cell lung cancer	down	Decreased expression of microRNA-375 in nonsmall cell lung cancer and its clinical significance.
hsa-mir-375	oral cancer	down	MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
hsa-mir-375	oral carcinoma	down	Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma.
hsa-mir-375	pancreatic ductal adenocarcinoma	down	Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.
hsa-mir-375	pancreatic ductal adenocarcinoma	down	Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-375	squamous carcinoma	down	Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma.
hsa-mir-376a	hepatocellular carcinoma	down	miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma.
hsa-mir-376a	malignant melanoma	down	Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.
hsa-mir-376a	pancreatic ductal adenocarcinoma	up	Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-376c	malignant melanoma	down	Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.
hsa-mir-376c	osteosarcoma	down	MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
hsa-mir-376c	osteosarcoma	down	MicroRNA-376c Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting to Transforming Growth Factor-Alpha.
hsa-mir-378	acute myeloid leukemia	up	Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia.
hsa-mir-378	colorectal cancer	down	Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
hsa-mir-378	gastric cancer	down	MicroRNA profiling of human gastric cancer.
hsa-mir-378	gastric cancer	down	MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer.
hsa-mir-381	breast cancer	down	Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-381	lung adenocarcinoma	down	MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinoma.
hsa-mir-383	glioma	down	Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor.
hsa-mir-383	medulloblastoma	down	MiR-383 is Downregulated in Medulloblastoma and Targets Peroxiredoxin 3 (PRDX3).
hsa-mir-409-3p	gastric cancer	down	MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers.
hsa-mir-409-3p	gastric cancer	down	MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer.
hsa-mir-421	gastric cancer	up	Increased expression of miR-421 in human gastric carcinoma and its clinical association.
hsa-mir-421	nasopharyngeal carcinoma	up	miR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4.
hsa-mir-422a	colorectal cancer	down	Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
hsa-mir-423	hepatocellular carcinoma	up	MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma.
hsa-mir-424	cervical cancer	down	Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.
hsa-mir-424	colorectal cancer	up	Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-424	osteosarcoma	down	Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase.
hsa-mir-424	ovarian cancer	up	MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-424-5p	pancreatic cancer	up	MicroRNA-424-5p Suppresses the Expression of SOCS6 in Pancreatic Cancer.
hsa-mir-425	breast cancer	down	Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.
hsa-mir-429	colorectal cancer	up	MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2.
hsa-mir-429	gastric cancer	down	miR-429 modulates the expression of c-myc in human gastric carcinoma cells.
hsa-mir-433	gastric cancer	down	Down-regulated miR-9 and miR-433 in human gastric carcinoma.
hsa-mir-449	gastric cancer	down	miR-449 inhibits cell proliferation and is down-regulated in gastric cancer.
hsa-mir-449a	lung cancer	down	Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer.
hsa-mir-449a	non-small cell lung cancer	down	MicroRNA-449a Is Downregulated in Non-Small Cell Lung Cancer and Inhibits Migration and Invasion by Targeting c-Met.
hsa-mir-449a	prostate cancer	down	miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.
hsa-mir-449a	prostate cancer	down	miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.
hsa-mir-449b	lung cancer	down	Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer.
hsa-mir-450a	hepatocellular carcinoma	down	microRNA-450a targets DNA methyltransferase 3a in hepatocellular carcinoma.
hsa-mir-451	esophageal carcinoma	down	Effect of miR-451 on the Biological Behavior of the Esophageal Carcinoma Cell Line EC9706.
hsa-mir-451	glioma	down	MiRNA-451 plays a role as tumor suppressor in human glioma cells.
hsa-mir-451	glioma	down	MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma.
hsa-mir-451	hepatocellular carcinoma	down	miR-451 Inhibits Cell Proliferation in Human Hepatocellular Carcinoma through Direct Suppression of IKK-?
hsa-mir-451	non-small cell lung cancer	down	The expression and function of miRNA-451 in non-small cell lung cancer.
hsa-mir-451	non-small cell lung cancer	down	Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
hsa-mir-451	non-small cell lung cancer	down	MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
hsa-mir-452	glioma	down	Downregulation of miR-452 Promotes Stem-Like Traits and Tumorigenicity of Gliomas.
hsa-mir-483-3p	adrenal cortical carcinoma	up	The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-483-5p	adrenal cortical carcinoma	up	miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer.
hsa-mir-483-5p	adrenal cortical carcinoma	up	The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-483-5p	glioblastoma	down	MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.
hsa-mir-483-5p	glioma	down	MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.
hsa-mir-485-3p	hepatocellular carcinoma	up	MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.
hsa-mir-486	glioma	up	miR-486 sustains NF-?B activity by disrupting multiple NF-?B-negative feedback loops.
hsa-mir-486-5p	lung cancer	down	Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer.
hsa-mir-490-3p	hepatocellular carcinoma	up	miR-490-3p Modulates Cell Growth and Epithelial to Mesenchymal Transition of Hepatocellular Carcinoma Cells by Targeting Endoplasmic Reticulum-Golgi Intermediate Compartment Protein 3 (ERGIC3).
hsa-mir-490-5p	bladder cancer	down	MicroRNA expression signatures of bladder cancer revealed by deep sequencing.
hsa-mir-492	hepatoblastoma	up	MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma.
hsa-mir-493	bladder cancer	down	Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.
hsa-mir-493	pituitary carcinoma	up	MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas.
hsa-mir-495	breast cancer	up	miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1.
hsa-mir-495	glioma	down	MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6.
hsa-mir-495	hepatocellular carcinoma	up	MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.
hsa-mir-497	adrenal cortical carcinoma	down	The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-497	breast cancer	down	Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer.
hsa-mir-497	cervical cancer	down	MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
hsa-mir-497	colorectal cancer	down	MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer.
hsa-mir-497	non-small cell lung cancer	down	Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer.
hsa-mir-498	ovarian cancer	down	1,25-Dihydroxyvitamin D3 Suppresses Telomerase Expression and Human Cancer Growth through MicroRNA-498.
hsa-mir-499-5p	colorectal cancer	up	MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4.
hsa-mir-500	hepatocellular carcinoma	up	MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.
hsa-mir-501	hepatocellular carcinoma	up	MicroRNA-501 promotes HBV replication by targeting HBXIP.
hsa-mir-502	colon cancer	down	Inhibition of autophagy and tumor growth in colon cancer by miR-502.
hsa-mir-503	ovarian cancer	up	MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-508-3p	kidney cancer	down	Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.
hsa-mir-509-3p	kidney cancer	down	Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.
hsa-mir-509-5p	renal cell carcinoma	down	Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma.
hsa-mir-511	lung adenocarcinoma	down	miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2.
hsa-mir-517a	breast cancer	down	Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines.
hsa-mir-518b	esophageal squamous cell carcinoma	down	miR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma.
hsa-mir-519d	hepatocellular carcinoma	down	MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703.
hsa-mir-519d	hepatocellular carcinoma	up	In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
hsa-mir-520c-3p	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-520c-3p	hepatocellular carcinoma	down	MicroRNA-520c-3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican-3.
hsa-mir-532-5p	malignant melanoma	up	Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
hsa-mir-532-5p	ovarian carcinoma	down	MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.
hsa-mir-541	pancreatic ductal adenocarcinoma	up	Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-544	gastric cancer	up	Oncogenic miR-544 is an Important Molecular Target in Gastric Cancer.
hsa-mir-564	chronic myelogenous leukemia	down	Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
hsa-mir-573	malignant melanoma	down	miR-573 regulates melanoma progression by targeting the melanoma cell adhesion molecule.
hsa-mir-574-3p	breast cancer	down	Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines.
hsa-mir-574-3p	hepatocellular carcinoma	up	Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
hsa-mir-575	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-590-5p	hepatocellular carcinoma	up	MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-? RII.
hsa-mir-590-5p	hepatocellular carcinoma	down	MiR-590-5P Inhibits Growth of HepG2 Cells via Decrease of S100A10 Expression and Inhibition of the Wnt Pathway.
hsa-mir-601	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-612	hepatocellular carcinoma	down	miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma.
hsa-mir-616*	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-622	gastric cancer	down	Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene.
hsa-mir-625	gastric cancer	down	Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK.
hsa-mir-625*	non-small cell lung cancer	down	Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.
hsa-mir-627	colonic adenocarcinoma	down	MicroRNA-627 Mediates the Epigenetic Mechanisms of Vitamin D to Suppress Proliferation of Human Colorectal Cancer Cells and Growth ofXenograft Tumors in Mice.
hsa-mir-630	pancreatic cancer	down	Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R.
hsa-mir-637	hepatocellular carcinoma	down	Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling.
hsa-mir-638	gastric cancer	down	MicroRNA profiling of human gastric cancer.
hsa-mir-639	bladder cancer	up	Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?
hsa-mir-650	gastric cancer	up	MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity.
hsa-mir-650	hepatocellular carcinoma	up	Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma.
hsa-mir-657	hepatocellular carcinoma	up	MiR-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through NF-?B pathways.
hsa-mir-663	gastric cancer	down	Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells.
hsa-mir-663	lung cancer	up	MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation.
hsa-mir-663	nasopharyngeal carcinoma	up	MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.
hsa-mir-664	hepatocellular carcinoma	up	MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.
hsa-mir-675	colon cancer	up	Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer.
hsa-mir-7	breast cancer	down	MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression.
hsa-mir-7	glioblastoma	down	microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma.
hsa-mir-7	glioma	down	MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism.
hsa-mir-7	hepatocellular carcinoma	down	miR-7 inhibits tumor growth and metastasis by targeting the PI3K/AKT pathway in hepatocellular carcinoma.
hsa-mir-7	lung cancer	up	EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
hsa-mir-7-5p	malignant melanoma	down	miRNA-7-5p inhibits melanoma cell migration and invasion.
hsa-mir-874	head and neck squamous cell carcinoma	down	Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.
hsa-mir-885-5p	hepatocellular carcinoma	up	Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
hsa-mir-885-5p	neuroblastoma	down	MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival.
hsa-mir-886-3p	thyroid cancer	down	MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer.
hsa-mir-886-5p	cervical carcinoma	down	MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells.
hsa-mir-9	gastric adenocarcinoma	down	Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma.
hsa-mir-9	gastric cancer	down	Down-regulated miR-9 and miR-433 in human gastric carcinoma.
hsa-mir-9	gastric cancer	down	Aberrant hypermethylation of miR-9 genes in gastric cancer.
hsa-mir-9	gastric cancer	down	Development of a novel microRNA promoter microarray for ChIP-on-chip assay to identify epigenetically regulated microRNAs.
hsa-mir-9	gastric cancer	down	microRNA-9 Suppresses the Proliferation, Invasion and Metastasis of Gastric Cancer Cells through Targeting Cyclin D1 and Ets1.
hsa-mir-9	glioma	up	[MiR-9 regulates the expression of CBX7 in human glioma].
hsa-mir-9	glioma	up	The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells.
hsa-mir-9	malignant melanoma	down	MicroRNA-9 up-regulates E-cadherin through inhibition of NF-?B1-Snail1 pathway in melanoma.
hsa-mir-9	ovarian cancer	down	MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
hsa-mir-9	uveal melanoma	down	MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-?B1 pathway.
hsa-mir-92	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-92	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-92	medulloblastoma	up	The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-92	neuroblastoma	up	MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
hsa-mir-92	pancreatic cancer	up	MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
hsa-mir-92a	breast cancer	down	Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration.
hsa-mir-92a	breast cancer	down	Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.
hsa-mir-92a	colorectal cancer	up	Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.
hsa-mir-92a	colorectal cancer	up	Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.
hsa-mir-92a	colorectal cancer	up	MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-92a	esophageal squamous cell carcinoma	up	microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin.
hsa-mir-92a	hepatocellular carcinoma	up	Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development.
hsa-mir-92a	malignant melanoma	up	Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-93	colon cancer	down	Clinical significance of microRNA-93 downregulation in human colon cancer.
hsa-mir-93	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-95	colorectal cancer	up	MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma.
hsa-mir-95	colorectal carcinoma	up	MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma.
hsa-mir-96	bladder cancer	up	MicroRNA expression signatures of bladder cancer revealed by deep sequencing.
hsa-mir-96	bladder cancer	up	Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.
hsa-mir-96	breast cancer	up	Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a.
hsa-mir-96	chronic myelogenous leukemia	up	Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
hsa-mir-96	colorectal cancer	up	Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.
hsa-mir-96	glioma	up	The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas.
hsa-mir-96	ovarian cancer	up	The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimul
hsa-mir-96	pancreatic cancer	down	miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer.
hsa-mir-96	prostate cancer	up	miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells.
hsa-mir-98	esophageal squamous cell carcinoma	down	MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.
hsa-mir-98	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-99a	esophageal squamous cell carcinoma	down	MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma.
hsa-mir-99a	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-99a	hepatocellular carcinoma	down	MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.
hsa-mir-99a	hepatocellular carcinoma	down	Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.
hsa-mir-99b	lung cancer	down	microRNA-99b acts as a tumor suppressor in non-small cell lung cancer by directly targeting fibroblast growth factor receptor 3.